Specific Structural Requirements for the Inhibitory Effect of Thapsigargin on the Ca2+ ATPase SERCA
Open Access
- 1 April 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (17) , 17973-17979
- https://doi.org/10.1074/jbc.m313263200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inorganic and organic phosphate measurements in the nanomolar rangePublished by Elsevier ,2004
- Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoproteinPublished by Elsevier ,2003
- Drug Binding in Human P-glycoprotein Causes Conformational Changes in Both Nucleotide-binding DomainsJournal of Biological Chemistry, 2003
- Ca2+-ATPase structure in the E1 and E2 conformations: mechanism, helix–helix and helix–lipid interactionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2002
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Specific Substitutions at Amino Acid 256 of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transport ATPase Mediate Resistance to Thapsigargin in Thapsigargin-resistant Hamster CellsJournal of Biological Chemistry, 1998
- Synthesis of a Radioactive Azido Derivative of Thapsigargin and Photolabeling of the Sarcoplasmic Reticulum ATPaseBiochemistry, 1997
- The inhibitors thapsigargin and 2,5‐di(tert‐butyl)‐1,4‐benzohydroquinone favour the E2 form of the Ca2+, Mg2+‐ATPaseFEBS Letters, 1992
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989
- A factor preventing the major head protein of bacteriophage T4 from random aggregationJournal of Molecular Biology, 1970